MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has launched its M...
Sanofi is all in on AI and wants to become the first biopharma company powered by AI at scale. The company is using AI to chase the miracles of science b...
-Seqera, the leading software provider for complex data analysis in the life sciences space, announced the launch of Seqera Containers, a no-cost, stream...
Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-m...
The life science group Sartorius is expanding its multidisciplinary collaboration with NVIDIA to help enable the development of new and better therapies, c...
Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, fro...
Bruker Corporation announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European ...
First-quarter 2024 total net sales were $610.8 million, a decrease of 9.8 percent compared to $676.8 million reported for the first quarter of 2023...
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced the launch of Epidemiology Intelligence™. The new sol...
KCAS Bio continues to deliver against both growth objectives and more integrated customer service offerings. KCAS Bio has partnered with Crux Biolabs, a le...
BBI Solutions OEM Limited (BBI), a trusted expert provider of end-to-end solutions for the development of high-performance assays, has signed a partnership...
Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancer Mariana Oncology ...
Thermo Fisher Scientific, the world leader in serving science, was proud to welcome Jozef Sikela, Minister of Industry and Trade of the Czech Republic, alo...
CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by...
© 2024 Biopharma Boardroom. All Rights Reserved.
